SHL Telemedicine expands Israel offering with at-home Biomarker blood tests

SHL Telemedicine announced that it has expanded its offering in Israel to include the ability to perform at-home Biomarker blood tests. This diagnostic tool is designed to rapidly identify cardiac markers for detection of a heart attack. Following concerns of a cardiac event, the addition of the Biomarker test provides a snapshot, similar to an emergency room assessment, by combining this blood test with a detailed medical history and a 12-lead ECG transmission. This trio of diagnostic elements, now all available from home with SHL Telemedicine, will aid in identifying cardiac events during the symptomatic phase.